Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They have to pay their own bills. Advent is a contract supplier managing their now licensed factory. In biotech, that is a necessary cost. Regional financing however, requires them to provide services locally, and Advent pays rent for their office space dedicated to more broadly.
Squeezing it is not imploding. I expect you will be buying with your actual accounts when approval happens. You all swing trade this and do your damage because that is easy money. Do something actually valuable in the world why don’t you.
Well, this is not true. DCVax-L is submitted for approval for commercial sale and production and they have the right to produce it in advance of approval, in a humanitarian basis and charge the full cost. I have never in my life seen a company given such liberal permission, for a treatment YOU and the short acolytes claim is a failed treatment. Now why in the world would the UK prosecute a company like Apple for making claims about its chips, and then allow a small American company to charge patients who are dying, in a highly regulated market for drugs, the full cost of a “failed drug”…
The short case is crap, you all know it and you post incessantly every morning and all day and all night because you know that if you do not keep up the stream of constant lies, the truth will be widely apparent. The only way to stop it is to keep posting this nonsense since the company itself can’t market or make claims. That is prohibited for this market.
So you all lie, 24-7-365, and you’ll do it all holiday weekend as well. No rest for those who must lie asap function of their occupations, I guess.
Dude, so much of that is made up it is ridiculous. Their CDMO was bought out. Their trial ended production years ago and they let it run for the survival data. The CDMO they used would have cost them many millions to rescale at its own facilities. They instead bought Flaskworks, did a sale leaseback if very valuable property they had bought years before for manufacturing in the UK and for regional financing to build the factory they built. The current CDMO was a spinoff from the previous one and since the founder here helped build that CDMO she was able to get it and preserve the knowledge from the main firm since the spinoff did some part of the manufacturing for the UK previously.
In the interim, they have with the regional financing making this a condition of financing, used their spare and unused space for now, as a symbiotic facility for local Cambridge researchers and companies, so that the region can continue to develop its biotech sector.
But according to your ridiculous scenario, it’s all a con, with UCLA and King’s College’s full support… give it a fricking break!
I hate to tell you this but these microcap, pre-revenue, biotech stocks are always squeezed before an approval. Often it is a very, very hard squeeze.
Replies are not about the shorts or to “convince them”, any more than their posts are for me or others who firmly believe in DCVax-L.
Except the posts are not for you. Blindness doesn’t help with ensuring such false messages don’t dominate the narrative.
These bashers bash every morning before opening. They act as if things that happen are avoidable and unknown. This is a pre-revenue company with an application pending. Issuing shares is how such companies pay their bills. That part is predictable and normal. But of course if you’re a swing trader and trying to get the price down because you’re currently short, and also trying to INCREASE dilution by keeping what the company can receive for every issued share low, of course these are the tactics you aggressively pursue every morning. They are like gnats, or flies, in their activity and annoyance.
And of course they lie or don’t disclose their position. That is all a part of this kind of a shakedown. It’s pure mafia. It ‘ould be a shame if something “ould happen to your company… oh, do people show up every morning “fearing for your demise” on public message boards? Such a shame. The mafia guys say… because they “care”… they say.
These guys are disgusting.
I am not going to waste my time. You have said it. In the far past. But to find such a post in a message board is a long hunt and pick and to be honest, while I am invested here, I do not care to waste my time for the most part, with that kind of necessary validation of how dishonest shorts are, broadly and specifically.
You have been saying it for years, but now that you know it is relevant to your credibility, you’re denying you said it. You said it before the last authorization, claiming they had many more shares issued than authorized, another of your ripe old claims.
Dd not say “there are people selling” for the reasons you describe. I was speaking to known shorts who have posted here for years without disclosing their position because that would be adverse to their being taken seriously.
What I said is true. You may have psyched yourself into believing you tell the truth, but everyone here knows that you exaggerate your case always and fudge facts to make your claims seem legitimate.
A casual read of the 10Q characterizes the broader categories you assembled and it does not change what I said either now or in the past. You have said 1.5 to 1.75 B shares since I do not know when, when now, by your admission, it was only 450,000,000.
You’re revising your past. Further no one advocates for more shares. What a common shareholder should do is to ensure a company has the cash, including authorized shares to avoid bankruptcy, where they are at the bottom of the heap in any workout or liquidation. For naked shorts and others, a bankruptcy and denying a company capital is what it is ALL about. Pushing them into bankruptcy, accelerating their dilution and then complaining about it, this is what you all do for a living. It’s basically theft by disinformation and misinformation.
If not paid back in some instances and if converted before the company could converts. You did not actually contradict anything I said.
At least since the company, as you said, had 450,000,000 shares outstanding and I arrived, you have always exaggerated what shares are already outstanding. At that time you said there were 1.5 billion, when there were not, in fact, anywhere near 1.5 billion. It may make sense on a buyout to assume all are converted, but at this moment, the potential shares that are cost in other forms are not actually converted and some may be paid back as debt payments before they are converted.
When shorts squeeze share prices down to accelerate dilution and then “complain” about dilution… that’s ripe.
I never made any such claim. That you need to exaggerate what other people say in your answer here, is what this is all about. Because you can’t really rely on facts apparently. Never have. Neither does your alter ego.
You have to read to know what is what and what may be converted and what may not be converted. You had to add things that may not become shared and I don’t have time ti spare for you. But those are not currently all traded, public shares and there is reason to never, ever trust what you post on this subject because of your history.
But yeah, you jump to convert things not yet issued and not necessarily to be issued as shares. They may be, just like authorized shares may become issued shares, but the point of a share count is to count what is public now and traded now. For a buyout, certain other issuances become more relevant IF they are convertible by the holder and are not paid back as cash before the conversion happens. And as I said, with large numbers, it is easy for people such as you to add lots of things together and make any over counting seem minor.
Doing your own come noting and claiming “it’s all in the financials” is a common claim of shorts that frequently turns out to be exaggerated
I don’t “campaign”, but I do oppose the idiocy of shorts. When such raises are denied for pre-commercial companies such as this, it leads to disasters for common shareholders, which is exactly what short hedge funds want.
You’re always destructive, and always under the pretense that “you care”.
Your non-factual nonsense and implied effort to scare people you mean. This is a pre-commercial entity. Most people here are likely to already know any risks and they are disclosed also in financial documents. Your “drivel” is what is unnecessary.
There you go with the failure to admit that was incorrect and then misdirection. The fact is, all companies have many more authorized shares than they hope to ever issue. If revenues become substantial, they can literally begin to use revenues not only to borrow if they need capital, but also to buy back shares. That you think you sound smart by posting that nonsense, is amusing but not thoughtful by any stretch of the imagination. It’s just a desire to avoid recognizing that shorts convolute different ideas to intentionally mislead retail.
You might rather argue that eventually NWBO will issue those shares, but then you actually have to admit that the shares are not currently outstanding, so adamantly pointing to the 10Q rather than admitting I was right and shorts exaggerate, and none of you will ever do that because you’re jobs require constant deception. And since shorts thrive on misinformation and deception, never admitting they lied, I guess we could expect this reply of yours.
No, and they are simply advising on what timeline they and the regulator thought was likely and possible when they applied. MHRA is new to this field, relatively, so fast for a regulator, doesn’t mean fast for people on investor boards.
You do understand that shares “authorized” for possible ultimate issuance, and shares actually issued, are two different things I hope.
You always say that as a way to bounce the comment. Please the actual link and quote from the Quarterly Financial report. Or as usual, are you adding things already included in the share count?
Because this popped so much on Friday, undoing months of intensive bashing to get the price down, these numbskulls have spent all weekend here bashing with misinformation trying to keep anyone from thinking it’s a run. Well, pops often do consolidate on the next trading day, no mystery, as shorts and swing traders adjust and manage their positions especially. But the intense work to keep it down says, it would not stay down but for this immense work they put in, and apparently they know that or they would not have been here, freaking out all weekend. The intensity of their posts telegraphs the fears of shorts and swing traders who likely were not ready for that run and had been working so hard to reenter likely at a much lower, targeted price. IMHO of course.
Advent has no decision making there. That means s NWBO’s ability or decision that will matter. The fact is, certain top research facilities and doctors would not have entrusted their new IP with a company that they expect is going down any instant with a failed approval. No expert in the field agrees with you. Some might have preferred they redo the trial, so that their own failed research could continue longer, but no major researcher has said regulators will disapprove or should disapprove of this treatment unless they are sponsored by the helmet company or they research that failed nonsense that got through a much less rigorous process and trial because it’s a device and not a drug.
Nonsense. You know so little and make so many really ridiculous pronouncements.
No idea what caused it here, but whether it gets knocked back Monday and if there is not news on Monday, it really doesn’t mean the start of a run is meaningless or doesn’t have something behind it. We just might not know immediately what that is.
They just make noise to scare away uninformed retail investors who might be curious. This is their job.
As I have said time and tine again, these swing trade manipulators work very hard ti squeeze microcaps down to as low as possible before ab expected approval. We were up 13% on Friday and their posts would suggest the opposite because they were taken by surprise. The intensity of their posts is all you need to know. if it were true, they would not beed to he posting so much noise, distraction and interference. They would likely not even be here. But they are here 34/7/365 fir years and years telling anyone and everyone, their manipulative narratives.
Not going to happen. Solid tumors and cancers are more complicated and the engineering is simply not that advanced for Car-T and it is in the nature of the tool itself to create the “side-effects” you dismiss. They are not side-effects, they are a direct result of the mechanism.
You have always over predicted the number of shares and warrants outstanding by at list 1.5 x authorized since I have been here and have consistently been wrong. The challenge is that the number is large and differences can sound alike. But nonetheless, I have no doubt you continue in your behavior.
You said they had 1.5 billion outstanding when they had 750,000,000. Why not just say they have a quadrillion? It’s what you would say if you could say it without totally discrediting yourself.
They do not have 2B shares.
You might as well be posting 20 x 1 quadrillion shares = 20 Quadrillion MC…
Some of the positive speculation is wild, no doubt, though understandable and typical, but the counter arguments, literally lie. No need to lie. Just make a legit point. You don’t agree with $20 B. You claim to be a long. Make a reasonable argument about a reasonable valuation.
I note you post this negatively in the contest of a not insignificant 13% pop in price.
No, that is the point of using the person’s OWN Dendritic cells and exposing them to the same person’s tumor antigens that do not belong. The JOB of these cells is to identify exactly that which does not belong. No other tool literally in existence does that better. This is leveraging a natural process evolved with our immune system. Yet you further invent a fake notion to spread fud for the people who literally do not understand the science here or what is going on.
Further, there is zero evidence of any autoimmune reaction as we see with purely engineered immunotherapies, like Car-T, which I am sure you have championed over the years in the “look over here” efforts at distraction that you and others engage in ceaselessly.
The challenge is that some fall in love with the excitement of literally reinventing nature, thinking they can “do it better.” But the reality is, if you can find a better way for nature to do its job, it is almost always universally understood as the best way.
Exactly. Sales to investors are sales to fund the company’s rapid approach toward commercialization. If they were NOT funding such efforts, THAT would be a serious problem. The fact that they are, is, in fact, a positive sign.
Investors at this stage could then be dumping those shares, sure, possibly. But not if they are not registered shares. So that also seems unlikely.
No matter how shorts try to twist it, it has been brilliantly executed and on a shoe string budget. They will twist anything, even amazingly great events, as we know, into some version of a “complete disaster!”
And legal fees connected with those applications can add quite a bit more to the cost.
Being aware of one’s own history and trying not to harm others, intentionally or inadvertently, is to be a good person. If you want to label being a good person in society, “woke”, that’s your choice, but it appears that is a way to numb people to the harm they do to others because some people benefit from a society where people harm one another intentionally or by means of systems.
Well, that sounds nice Gary, but the first step to doing that is addressing the harms we do, even, inadvertently, to others. And everyone knows that everyone can do and does do harm. So the first step is not being intentionally blind to those things because it makes one uncomfortable thinking about it.
I doubt that is the issue. Complex product, perhaps one of the most to be brought for approval with these drug agencies, ever, in terms of moving pieces and potential complexity and issues.
They are doing alright but yes, it takes a very long time. And it is literally difficult for most, if they do not have the resources or time, to wait it out. But no one needs to do so. There are plenty of great investments out there.
It is. Definitely. It is greed above all things. Closest thing I have seen to wishing money are the shorts who attack these companies undermining medical progress to trade and make money. Vandalism of the very most damaging and evil kind. It will, in the end, come at great cost. Maybe not obviously. But doing so much evil, all the time, though some may deceive themselves, it will infect every aspect of their life and their personality.
If you thought it was a scam, and were an “investor”, you would not waste ALL of your time here for years. No, you’re a swing trader and you make money on the ups and downs, with different ID’s, and that is the reality and why you are here morning, night and noon, every single day, holidays and weekends, 24-7-365, for years on end, posting non-stop. That is extremely obvious.
You put so much time in, denying reality, because faking out retail is lucrative, when you trade, and are doing it with highly regulated microcap bios, just not for retail… until they succeed. For traders, as some have posted in the past, “it’s easy money”, because you trade the swings. And that is why none of you disclose anything. You can’t, because you all are constantly in and out and shorting mostly.
With these companies, spreading fear and using necessary dilution are part of the trading strategy. And with other ID’s you may even hype sometimes.
They clearly have a very particular approach to the regulatory process. The timelines are from posters on bulletin boards mostly. They and we all should know the regulatory process can be involved and they are doing it with virtually no redundancy, for a product the likes of which has not been created before. None of the other treatments are as personalized and cell based as this one. They have not just one personalized angle, it’s not just the patient’s blood or immune cells, but the patient’s actual tumor used to train the cells. Nothing like this exists yet in any commercial form. So yeah, they are being methodical and careful.
Doubtful you, on this bulletin board are saying anything they do not know and have well in hand…
Obviously. Do you really think, given all the work on the MHRA platform you’re saying something that 2 regulatory lawyers with as much experience and depth as LP are not fully cognizant of and far along on? Give it a break!